These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8759616)

  • 1. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
    Chang SC; Buonaccorsi G; MacRobert A; Bown SG
    Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
    Chang SC; Chern IF; Hsu YH
    Proc Natl Sci Counc Repub China B; 1999 Oct; 23(4):158-66. PubMed ID: 10518316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
    Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
    Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
    Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
    Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats.
    Alian W; Andersson-Engels S; Svanberg K; Svanberg S
    Br J Cancer; 1994 Nov; 70(5):880-5. PubMed ID: 7947093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in the canine prostate using motexafin lutetium.
    Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
    Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
    Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
    Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster.
    Mlkvy P; Messmann H; Pauer M; Stewart JC; Millson CE; MacRobert AJ; Bown SG
    Br J Cancer; 1996 Jun; 73(12):1473-9. PubMed ID: 8664115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
    Aniola J; Selman SH; Lilge L; Keck R; Jankun J
    Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.
    Selman SH; Albrecht D; Keck RW; Brennan P; Kondo S
    J Urol; 2001 May; 165(5):1795-801. PubMed ID: 11342978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.
    Chang SC; Buonaccorsi GA; MacRobert AJ; Bown SG
    Prostate; 1997 Jul; 32(2):89-98. PubMed ID: 9215396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
    Braichotte DR; Savary JF; Monnier P; van den Bergh HE
    Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
    Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
    Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence and absorption assessment of a lipid mTHPC formulation following topical application in a non-melanotic skin tumor model.
    Johansson A; Svensson J; Bendsoe N; Svanberg K; Alexandratou E; Kyriazi M; Yova D; Gräfe S; Trebst T; Andersson-Engels S
    J Biomed Opt; 2007; 12(3):034026. PubMed ID: 17614734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilic photosensitizer administration via the prostate arteries for photodynamic therapy of the canine prostate.
    Xiao Z; Owen RJ; Liu W; Tulip J; Brown K; Woo T; Moore RB
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):106-14. PubMed ID: 20510305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.